These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 8423551)

  • 1. Hormonal and cardiovascular effects of losartan (DuP753), an angiotensin receptor antagonist, in nonhuman primates.
    DeGraaf GL; Pals DT; Couch SJ; Lawson JA
    J Pharmacol Exp Ther; 1993 Jan; 264(1):6-10. PubMed ID: 8423551
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acute and chronic effects of losartan (DuP 753) on blood pressure and vascular reactivity in normotensive rats.
    Soltis EE; Jewell AL; Dwoskin LP; Cassis LA
    Clin Exp Hypertens; 1993 Jan; 15(1):171-84. PubMed ID: 8467311
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential effects of oral losartan and enalapril on local venous and systemic pressor responses to angiotensin I and II in healthy men.
    Goldberg MR; de Mey C; Wroblewski JM; Li Q; Schroeter V; Belz GG
    Clin Pharmacol Ther; 1996 Jan; 59(1):72-82. PubMed ID: 8549037
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DuP 532, an angiotensin II receptor antagonist: first administration and comparison with losartan.
    Goldberg MR; Lo MW; Christ DD; Chiou R; Furtek CI; Amit O; Carides A; Biollaz J; Piguet V; Nussberger J; Brunner HR
    Clin Pharmacol Ther; 1997 Jan; 61(1):59-69. PubMed ID: 9024174
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of AT1 receptors in the central control of sympathetic vasomotor function.
    Head GA
    Clin Exp Pharmacol Physiol Suppl; 1996; 3():S93-8. PubMed ID: 8993846
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Beta adrenoceptor blockade in rabbit inhibits the renin-releasing effect of AT1 receptor antagonist losartan.
    Hajj-Ali AF; Wong PC
    J Pharmacol Exp Ther; 1993 Dec; 267(3):1423-7. PubMed ID: 7903389
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Blockade of the renin-angiotensin system in heart failure in conscious dogs.
    Murakami M; Suzuki H; Naitoh M; Matsumoto A; Kageyama Y; Tsujimoto G; Saruta T
    J Hypertens; 1995 Dec; 13(12 Pt 1):1405-12. PubMed ID: 8866902
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of losartan (DuP753) and enalaprilat on the mean arterial pressure response to phenylephrine.
    Madwed JB; Winquist RJ
    J Hypertens; 1994 Feb; 12(2):159-62. PubMed ID: 8021467
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Contribution of the renin-angiotensin system to the variability of blood pressure in hypertensive rat after blockade of nitric oxide synthesis].
    Gouédard O; Gaudet E; Blanc J; Ponchon P; Elghozi JL
    Arch Mal Coeur Vaiss; 1996 Aug; 89(8):1013-7. PubMed ID: 8949370
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacological study of SR 47436, a non-peptide angiotensin II AT1-receptor antagonist, in conscious monkeys.
    Lacour C; Roccon A; Cazaubon C; Segondy D; Nisato D
    J Hypertens; 1993 Nov; 11(11):1187-94. PubMed ID: 8301099
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Hormonal contribution to short-term variability of blood pressure in a renovascular hypertension model].
    Ponchon P; Elghozi JL
    Arch Mal Coeur Vaiss; 1995 Aug; 88(8):1203-7. PubMed ID: 8572874
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chronic blockade of AT2-subtype receptors prevents the effect of angiotensin II on the rat vascular structure.
    Levy BI; Benessiano J; Henrion D; Caputo L; Heymes C; Duriez M; Poitevin P; Samuel JL
    J Clin Invest; 1996 Jul; 98(2):418-25. PubMed ID: 8755652
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Juxtaglomerular cell hypertrophy and hyperplasia induced in rhesus monkeys by angiotensin II receptor antagonists.
    Owen RA; Molon-Noblot S; Hubert MF; Siegl PK; Eydelloth RS; Keenan KP
    Lab Invest; 1994 Oct; 71(4):543-51. PubMed ID: 7967510
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of the angiotensin II receptor antagonist Losartan (DuP 753/MK 954) on arterial blood pressure, heart rate, plasma concentrations of angiotensin II and renin and the pressor response to infused angiotensin II in the salt-deplete dog.
    MacFadyen RJ; Tree M; Lever AF; Reid JL
    Clin Sci (Lond); 1992 Nov; 83(5):549-56. PubMed ID: 1335390
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Peripheral administration of AT1 receptor blockers and pressor responses to central angiotensin II and sodium.
    Zhang J; Leenen FH
    Can J Physiol Pharmacol; 2001 Oct; 79(10):861-7. PubMed ID: 11697745
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical experience with angiotensin II receptor antagonists.
    Lee RJ; Brunner HR
    J Hum Hypertens; 1993 Aug; 7 Suppl 2():S33-6. PubMed ID: 8230087
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The diversified pharmacology of angiotensin II-receptor blockade.
    Timmermans PB; Smith RD
    Blood Press Suppl; 1996; 2():53-61. PubMed ID: 8913541
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of angiotensin II blockade on cardiac hypertrophy and remodelling: a review.
    Dahlöf B
    J Hum Hypertens; 1995 Nov; 9 Suppl 5():S37-44. PubMed ID: 8583480
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discovery of losartan, the first angiotensin II receptor antagonist.
    Timmermans PB; Duncia JV; Carini DJ; Chiu AT; Wong PC; Wexler RR; Smith RD
    J Hum Hypertens; 1995 Nov; 9 Suppl 5():S3-18. PubMed ID: 8583479
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Functional studies of nonpeptide angiotensin II receptor subtype-specific ligands: DuP 753 (AII-1) and PD123177 (AII-2).
    Wong PC; Hart SD; Zaspel AM; Chiu AT; Ardecky RJ; Smith RD; Timmermans PB
    J Pharmacol Exp Ther; 1990 Nov; 255(2):584-92. PubMed ID: 2243344
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.